There is a paradoxically positive correlation with elevated serum FGF21 levels and metabolic disorders like obesity, diabetes, mitochondrial diseases, and aging (Staiger et al., 2017; Tezze et al., 2017). This evidence concerns the gene FGF21 and obesity disorder.